Current research on PD-1 inhibitor-induced cardiotoxicity primarily centers on myocarditis mechanisms, with limited exploration into the mechanisms underlying PD-1 inhibitor-induced cardiac collagen remodeling. This evidence concerns the gene PDCD1 and myocarditis.